AGXT2 抗体 (AA 196-328) (Biotin)
-
- 抗原 See all AGXT2 抗体
- AGXT2 (Alanine Glyoxylate Aminotransferase 2 (AGXT2))
-
抗原表位
- AA 196-328
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This AGXT2 antibody is conjugated to Biotin
-
应用范围
- ELISA
- 交叉反应
- 人
- 纯化方法
- >95%, Protein G purified
- 免疫原
- Recombinant Human Alanine--glyoxylate aminotransferase 2, mitochondrial protein (196-328AA)
- 亚型
- IgG
- Top Product
- Discover our top product AGXT2 Primary Antibody
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C,-80 °C
- 储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- 抗原
- AGXT2 (Alanine Glyoxylate Aminotransferase 2 (AGXT2))
- 别名
- AGXT2 (AGXT2 产品)
- 别名
- AGT2 antibody, DAIBAT antibody, AI303810 antibody, AI663818 antibody, T19P19.50 antibody, T19P19_50 antibody, alanine:glyoxylate aminotransferase 2 antibody, im:7153274 antibody, zgc:114195 antibody, alanine--glyoxylate aminotransferase 2 antibody, alanine-glyoxylate aminotransferase 2 antibody, alanine:glyoxylate aminotransferase 2 antibody, AGXT2 antibody, Agxt2 antibody, AGT2 antibody, agxt2 antibody
- 背景
-
Background: Can metabolize asymmetric dimethylarginine (ADMA) via transamination to alpha-keto-delta-(NN-dimethylguanidino) valeric acid (DMGV). ADMA is a potent inhibitor of nitric-oxide (NO) synthase, and this activity provides mechanism through which the kidney regulates blood pressure.
Aliases: AGXT2 antibody, AGT2Alanine--glyoxylate aminotransferase 2 antibody, mitochondrial antibody, AGT 2 antibody, EC 2.6.1.44, antibody, R)-3-amino-2-methylpropionate--pyruvate transaminase antibody, EC 2.6.1.40 antibody, Beta-ALAAT II antibody, Beta-alanine-pyruvate aminotransferase antibody, D-AIBAT antibody
- UniProt
- Q9BYV1
- 途径
- Monocarboxylic Acid Catabolic Process
-